Is it the end of mouthwash as an intervention for gonorrhoea?
- PMID: 34051184
- DOI: 10.1016/S1473-3099(21)00195-X
Is it the end of mouthwash as an intervention for gonorrhoea?
Conflict of interest statement
EPFC and CKF are investigators in the OMEGA trial. The OMEGA trial was funded by a National Health and Medical Research Council (NHMRC) project grant (GNT1122514). EPFC is supported by an Australian NHMRC Emerging Leadership investigator grant (GNT1172873). CKF is supported by an Australian NHMRC Leadership investigator grant (GNT1172900). We thank Ei Aung and Elena Rodriguez at the Melbourne Sexual Health Centre (Melbourne, VIC, Australia) for their assistance in assessing the risk of bias for the included studies.
Comment on
-
Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.Lancet Infect Dis. 2021 May;21(5):647-656. doi: 10.1016/S1473-3099(20)30704-0. Epub 2021 Mar 4. Lancet Infect Dis. 2021. PMID: 33676595 Clinical Trial.
-
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.Lancet Infect Dis. 2021 May;21(5):657-667. doi: 10.1016/S1473-3099(20)30778-7. Epub 2021 Mar 4. Lancet Infect Dis. 2021. PMID: 33676596 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
